Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Castleton Seeks Shareholder Approval To Cancel Premium Account

Fri, 07th Sep 2018 12:40

LONDON (Alliance News) - Castleton Technology PLC on Friday said it intends to cancel its share premium account and create distributable profit.

As at March 31, Castleton had a GBP9.8 million deficit on its profit and loss account and had no distributable profit with which to fund share buybacks or make distributions. However, its premium account had an GBP18.8 million credit.

The software and managed services provider will, therefore, seek approval from its shareholders to cancel the premium account, eliminate the deficit, and make distributions.

A general meeting will be held in the last week of September, at which point shareholders will vote on the proposal. The premium cancellation is has the unanimous recommendation of Castleton's directors.

Shares in Castleton Technology were down 1.4% at 101.06 pence on Friday.

Related Shares

More News
26 May 2020 18:45

Castleton Technology Shareholders Back GBP83 Million Takeover By MRI

Castleton Technology Shareholders Back GBP83 Million Takeover By MRI

15 Apr 2020 12:02

Castleton Technology Accepts GBP82 Million MRI Software Offer

Castleton Technology Accepts GBP82 Million MRI Software Offer

12 Dec 2019 14:23

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Oxford Technology VCTs Report Mixed Third-Quarter Performances

5 Nov 2019 11:09

Castleton Expects Second Half Improvement After Tricky Interim

Castleton Expects Second Half Improvement After Tricky Interim

5 Nov 2019 10:38

UK WINNERS & LOSERS SUMMARY: AB Foods Rises As Primark Adds US Stores

UK WINNERS & LOSERS SUMMARY: AB Foods Rises As Primark Adds US Stores

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.